Development and validation of a fully automated laboratory-developed test for detection of HSV-1/2 and VZV in clinical samples run on the Panther Fusion® system

Diagn Microbiol Infect Dis. 2023 Oct;107(2):116022. doi: 10.1016/j.diagmicrobio.2023.116022. Epub 2023 Jul 11.

Abstract

The purpose of this study was to develop a laboratory developed test (LDT) for HSV1/2 and VZV to run on fully automated Hologic Panther Fusion® System. The Panther Fusion System is a fully automated walkaway system, providing end-to-end workflow from sample input to DNA/RNA extraction, amplification, automated analysis, and reporting to a laboratory information system (LIS). The LDT was developed and validated on 230 clinical and 20 reference samples (n = 250) and compared to a commercially available kit. Assessment of the analytical and diagnostic performances of the LDT revealed >98% accuracy, sensitivity, and specificity, which is consistent with or better than many of the commercial or laboratory-developed tests available. The advantage of this LDT is that it is designed to perform a single-run full female health screening in parallel with 4 commercially available Hologic kits for Chlamydia trachomatis/Neisseria gonorrhea (CT/NG), Trichomonas vaginalis (TV), Mycoplasma genitalium (MG), and bacterial vaginosis (BV).

Keywords: Herpes simplex virus (HSV) 1 & 2; Laboratory-developed test; Multiplex PCR; Varicella-zoster virus (VZV).

MeSH terms

  • Chlamydia trachomatis / genetics
  • Female
  • Gonorrhea* / diagnosis
  • Herpesvirus 1, Human* / genetics
  • Herpesvirus 2, Human
  • Humans
  • Neisseria gonorrhoeae / genetics
  • Sensitivity and Specificity
  • Vaginosis, Bacterial*